secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solana Co (HSDT)
CIK:        0001610853
Form:       8-K
Filed at:   2023-08-10T23:59:59+00:00
Accession:  0001558370-23-014508
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Helius Medical Q2 revenue up 115% YoY to $256K; net loss narrows to $1.6M
-------------------------------------------------------------------------

- Q2 2023 revenue $256K vs $119K in Q2 2022 (+115%); PoNS sales driven by PTAP which ended June 30.
- Net loss $1.6M ($0.06 per share) vs $3.8M ($0.97) prior year; operating loss $3.2M.
- Cash $8.6M at June 30, 2023; no debt; cash burn $2.7M in Q2 (down $0.9M YoY).
- PoNS device awarded DMEPOS accreditation by CMS-authorized TCT, a step toward Medicare reimbursement.
- Guidance: Q3 and FY2023 revenue expected above prior year; U.S. sales to shift to cash-pay post-PTAP.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1610853/000155837023014508/0001558370-23-014508-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1610853/000155837023014508/hsdt-20230810x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-014508

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer